This variant is the first pathogenic splice-site variant identified in LMOD2, providing important additional evidence supporting the association of LMOD2 loss-of-function variants with severe DCM and cardiac thin filament shortening. This evidence concerns the gene LMOD2 and familial dilated cardiomyopathy.